Urinary 8-iso-prostaglandin F2α as a risk marker in patients with coronary heart disease -: A matched case-control study

被引:232
作者
Schwedhelm, E
Bartling, A
Lenzen, H
Tsikas, D
Maas, R
Brümmer, J
Gutzki, FM
Berger, J
Frölich, JC
Böger, RH
机构
[1] Univ Hamburg, Hosp Eppendorf, Inst Expt & Klin Pharmakol, Clin Pharmacol Unit, D-20246 Hamburg, Germany
[2] Univ Hamburg, Hosp Eppendorf, Inst Clin Chem, D-20246 Hamburg, Germany
[3] Univ Hamburg, Hosp Eppendorf, Inst Math & Data Proc Med, D-20246 Hamburg, Germany
[4] Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany
关键词
prostaglandins; coronary disease; C-reactive protein; isoprostanes; risk factors;
D O I
10.1161/01.CIR.0000116761.93647.30
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Oxidative stress is involved in the pathophysiology of atherosclerosis, diabetes mellitus, hypertension, obesity, and cigarette smoking, all of these being risk factors for coronary heart disease (CHD). We tested the hypothesis that risk factors of CHD are associated with abundant systemic oxidative stress. Methods and Results - We conducted a case-control study with 93 CHD patients and 93 control subjects frequency-matched by age and sex. Urinary excretion of the F-2-isoprostane 8-iso-prostaglandin (PG) F-2alpha and its major urinary metabolite, 2,3-dinor-5,6-dihydro-8-iso-PGF(2alpha), were measured by gas chromatography - tandem mass spectrometry. Body mass index, systolic blood pressure, and C-reactive protein were elevated in CHD patients ( P < 0.01). Urinary 8-iso-PGF(2α) and 2,3-dinor-5,6-dihydro-8-iso-PGF(2α) also differed, from 77 (interquartile range, 61 - 101) to 139 ( 93 - 231) pmol/mmol creatinine and from 120 (91 - 151) to 193 (140 - 275) pmol/mmol in control subjects and case subjects, respectively (P < 0.001). 8-iso-PGF(2alpha) and its metabolite were highly correlated (Spearman's rho = 0.664, P < 0.001). HDL cholesterol was diminished in CHD patients ( P < 0.001). All of these characteristics predicted CHD in univariate analysis. In a multivariate model, the odds ratios were increased only for 8-iso-PGF(2alpha) (greater than or equal to131 pmol/mmol, P < 0.001) and C-reactive protein (>3 mg/ L, P < 0.01), ie, by 30.8 (95% CI, 7.7 - 124) and 7.2 (1.9 - 27.6), respectively. 8-iso-PGF(2α) was found to be a novel marker in addition to known risk factors of CHD, ie, diabetes mellitus, hypercholesterolemia, hypertension, and smoking. Urinary excretion of 8-iso-PGF(2α) correlated with the number of risk factors for all subjects ( P < 0.001 for trend). Conclusions - 8-iso-PGF(2alpha) is a sensitive and independent risk marker of CHD.
引用
收藏
页码:843 / 848
页数:6
相关论文
共 29 条
  • [1] Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina
    Cipollone, F
    Ciabattoni, G
    Patrignani, P
    Pasquale, M
    Di Gregorio, D
    Bucciarelli, T
    Davì, G
    Cuccurullo, F
    Patrono, C
    [J]. CIRCULATION, 2000, 102 (09) : 1007 - 1013
  • [2] Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications
    Cracowski, JL
    Durand, T
    Bessard, G
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (08) : 360 - 366
  • [3] Platelet activation in obese women -: Role of inflammation and oxidant stress
    Davì, G
    Guagnano, MT
    Ciabattoni, G
    Basili, S
    Falco, A
    Marinopiccoli, M
    Nutini, M
    Sensi, S
    Patrono, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16): : 2008 - 2014
  • [4] Davì G, 1999, CIRCULATION, V99, P224
  • [5] In vivo formation of 8-epi-prostaglandin F-2 alpha is increased in hypercholesterolemia
    Davi, G
    Alessandrini, P
    Mezzetti, A
    Minotti, G
    Bucciarelli, T
    Costantini, F
    Cipollone, F
    Bon, GB
    Ciabattoni, G
    Patrono, C
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 3230 - 3235
  • [6] Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects -: No further effect of vitamin E
    De Caterina, R
    Cipollone, F
    Filardo, FP
    Zimarino, M
    Bernini, W
    Lazzerini, G
    Bucciarelli, T
    Falco, A
    Marchesani, P
    Muraro, R
    Mezzetti, A
    Ciabattoni, G
    [J]. CIRCULATION, 2002, 106 (20) : 2543 - 2549
  • [7] Role of oxidative stress in cardiovascular diseases
    Dhalla, NS
    Temsah, RM
    Netticadan, T
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 (06) : 655 - 673
  • [8] Mechanisms of disease - Antioxidants and atherosclerotic heart disease
    Diaz, MN
    Frei, B
    Vita, JA
    Keaney, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) : 408 - 416
  • [9] Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes
    Ehara, S
    Ueda, M
    Naruko, T
    Haze, K
    Itoh, A
    Otsuka, M
    Komatsu, R
    Matsuo, T
    Itabe, H
    Takano, T
    Tsukamoto, Y
    Yoshiyama, M
    Takeuchi, K
    Yoshikawa, J
    Becker, AE
    [J]. CIRCULATION, 2001, 103 (15) : 1955 - 1960
  • [10] Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations - A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
    Grundy, SM
    Pasternak, R
    Greenland, P
    Smith, S
    Fuster, V
    [J]. CIRCULATION, 1999, 100 (13) : 1481 - 1492